Hans Moebius
Net Worth

Last updated:

What is Hans Moebius net worth?

The estimated net worth of Dr. Hans Moebius is at least $1,726,469 as of 2 Jun 2023. He owns shares worth $26,229 as insider and has received compensation worth at least $1,700,240 in Athira Pharma, Inc..

What is the salary of Hans Moebius?

Dr. Hans Moebius salary is $425,060 per year as Chief Medical Officer in Athira Pharma, Inc..

How old is Hans Moebius?

Dr. Hans Moebius is 68 years old, born in 1957.

What stocks does Hans Moebius currently own?

As insider, Dr. Hans Moebius owns shares in one company:

Company Title Shares Price per share Total value
Athira Pharma, Inc. (ATHA) Chief Medical Officer 65,836 $0.4 $26,229

What does Athira Pharma, Inc. do?

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.

Hans Moebius insider trading

Athira Pharma, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 7,882 $1.35 $10,641
Option
Stock Option (Right to Buy) 7,882 $1.35 $10,641
Purchase
Common Stock 5,000 $3.29 $16,440
Option
Common Stock 7,881 $1.35 $10,639
Option
Stock Option (Right to Buy) 7,881 $1.35 $10,639
Purchase
Common Stock 10,000 $2.88 $28,800
Option
Stock Option (Right to Buy) 28,372 N/A N/A
Option
Common Stock 28,372 N/A N/A
Option
Common Stock 28,372 $1.35 $38,302

Athira Pharma key executives

Athira Pharma, Inc. executives and other stock owners filed with the SEC: